Robert N. Schuck

1.4k total citations
43 papers, 855 citations indexed

About

Robert N. Schuck is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Economics and Econometrics. According to data from OpenAlex, Robert N. Schuck has authored 43 papers receiving a total of 855 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Endocrinology, Diabetes and Metabolism, 8 papers in Molecular Biology and 8 papers in Economics and Econometrics. Recurrent topics in Robert N. Schuck's work include Eicosanoids and Hypertension Pharmacology (8 papers), Statistical Methods in Clinical Trials (8 papers) and Health Systems, Economic Evaluations, Quality of Life (7 papers). Robert N. Schuck is often cited by papers focused on Eicosanoids and Hypertension Pharmacology (8 papers), Statistical Methods in Clinical Trials (8 papers) and Health Systems, Economic Evaluations, Quality of Life (7 papers). Robert N. Schuck collaborates with scholars based in United States, Thailand and Switzerland. Robert N. Schuck's co-authors include Craig R. Lee, Darryl C. Zeldin, Kenneth B. Tomer, Matthew L. Edin, Fred B. Lih, Katherine N. Theken, Michael Pacanowski, Laura M. DeGraff, Samuel M. Poloyac and George A. Stouffer and has published in prestigious journals such as Circulation, PLoS ONE and Nature Reviews Drug Discovery.

In The Last Decade

Robert N. Schuck

42 papers receiving 831 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robert N. Schuck United States 17 423 276 162 160 115 43 855
Vijay L. Manthati United States 14 559 1.3× 297 1.1× 211 1.3× 203 1.3× 40 0.3× 16 837
K. Lockhart Jamieson Canada 15 335 0.8× 151 0.5× 134 0.8× 113 0.7× 47 0.4× 23 549
Jeffrey E. Quigley United States 9 278 0.7× 295 1.1× 99 0.6× 112 0.7× 65 0.6× 10 666
Ketul R. Chaudhary Canada 17 414 1.0× 230 0.8× 176 1.1× 181 1.1× 35 0.3× 21 835
Arzu Ulu United States 21 1.1k 2.5× 415 1.5× 305 1.9× 351 2.2× 86 0.7× 67 1.8k
Jürgen R. Schaefer Germany 5 189 0.4× 175 0.6× 74 0.5× 55 0.3× 66 0.6× 11 500
Lucy Yang United States 15 207 0.5× 109 0.4× 75 0.5× 87 0.5× 118 1.0× 27 895
Ahmed M. Darwesh Canada 15 211 0.5× 353 1.3× 341 2.1× 71 0.4× 64 0.6× 27 913
Esther Knoll Israel 19 137 0.3× 299 1.1× 257 1.6× 411 2.6× 44 0.4× 37 1.1k
Anne M. Estes United States 19 349 0.8× 366 1.3× 274 1.7× 69 0.4× 30 0.3× 29 962

Countries citing papers authored by Robert N. Schuck

Since Specialization
Citations

This map shows the geographic impact of Robert N. Schuck's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert N. Schuck with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert N. Schuck more than expected).

Fields of papers citing papers by Robert N. Schuck

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert N. Schuck. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert N. Schuck. The network helps show where Robert N. Schuck may publish in the future.

Co-authorship network of co-authors of Robert N. Schuck

This figure shows the co-authorship network connecting the top 25 collaborators of Robert N. Schuck. A scholar is included among the top collaborators of Robert N. Schuck based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert N. Schuck. Robert N. Schuck is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sabarinath, Sreedharan, et al.. (2025). Trends in clinical studies evaluating neurofilament light chain as a biomarker. Biomarkers in Medicine. 19(17). 813–823.
2.
Li, Ruo‐Jing, et al.. (2025). Evaluation of the Landscape of Pharmacodynamic Biomarkers in GM1 and GM2 Gangliosidosis. Clinical and Translational Science. 18(3). e70176–e70176. 1 indexed citations
3.
Li, Ruo‐Jing, et al.. (2024). Clinical pharmacology considerations for first‐in‐human clinical trials for enzyme replacement therapy. Journal of Inherited Metabolic Disease. 47(5). 1096–1106. 1 indexed citations
4.
Schuck, Robert N., et al.. (2024). Evaluation of the landscape of pharmacodynamic biomarkers in Niemann-Pick Disease Type C (NPC). Orphanet Journal of Rare Diseases. 19(1). 280–280. 2 indexed citations
5.
Hyland, Paula L., et al.. (2024). Leveraging in Vitro Models for Clinically Relevant Rare CYP2D6 Variants in Pharmacogenomics. Drug Metabolism and Disposition. 52(3). 159–170. 1 indexed citations
6.
Bai, Jane P. F., et al.. (2023). Creating a Roadmap to Quantitative Systems Pharmacology–Informed Rare Disease Drug Development: A Workshop Report. Clinical Pharmacology & Therapeutics. 115(2). 201–205. 5 indexed citations
7.
Marcus, Leigh, M. Naomi Horiba, Martha Donoghue, et al.. (2022). FDA Approval Summary: Pemigatinib for Previously Treated, Unresectable Locally Advanced or Metastatic Cholangiocarcinoma with FGFR2 Fusion or Other Rearrangement. Clinical Cancer Research. 29(5). 838–842. 33 indexed citations
8.
Wang, Jie, et al.. (2022). Dose-finding studies in drug development for rare genetic diseases. Orphanet Journal of Rare Diseases. 17(1). 156–156. 6 indexed citations
9.
Schuck, Robert N., et al.. (2017). Leveraging Genomic Factors to Improve Benefit–Risk. Clinical and Translational Science. 10(2). 78–83. 3 indexed citations
10.
Wang, Nan, Kimberly C. Vendrov, Brian Simmons, et al.. (2017). Urinary 11-dehydro-thromboxane B2 levels are associated with vascular inflammation and prognosis in atherosclerotic cardiovascular disease. Prostaglandins & Other Lipid Mediators. 134. 24–31. 19 indexed citations
11.
Schuck, Robert N., Michael Pacanowski, Janet Woodcock, & Issam Zineh. (2017). Regulatory policy for the development of targeted therapies for low-frequency molecular subtypes of disease. Nature Reviews Drug Discovery. 17(2). 79–80. 6 indexed citations
12.
Ravi, Saranya, Robert N. Schuck, Eleanor Hilliard, et al.. (2017). Clinical Evidence Supports a Protective Role for CXCL5 in Coronary Artery Disease. American Journal Of Pathology. 187(12). 2895–2911. 35 indexed citations
13.
Schuck, Robert N. & Joseph A. Grillo. (2016). Pharmacogenomic Biomarkers: an FDA Perspective on Utilization in Biological Product Labeling. The AAPS Journal. 18(3). 573–577. 22 indexed citations
14.
Zha, Weibin, Matthew L. Edin, Kimberly C. Vendrov, et al.. (2014). Functional characterization of cytochrome P450-derived epoxyeicosatrienoic acids in adipogenesis and obesity. Journal of Lipid Research. 55(10). 2124–2136. 69 indexed citations
15.
Schuck, Robert N., et al.. (2014). Trial geography, pharmacogenetics, and global drug development. Clinical Pharmacology & Therapeutics. 97(3). 218–220. 4 indexed citations
16.
Oni‐Orisan, Akinyemi, Yangmei Deng, Robert N. Schuck, et al.. (2012). Dual modulation of cyclooxygenase and CYP epoxygenase metabolism and acute vascular inflammation in mice. Prostaglandins & Other Lipid Mediators. 104-105. 67–73. 21 indexed citations
17.
Theken, Katherine N., Robert N. Schuck, Matthew L. Edin, et al.. (2012). Evaluation of cytochrome P450-derived eicosanoids in humans with stable atherosclerotic cardiovascular disease. Atherosclerosis. 222(2). 530–536. 90 indexed citations
18.
Lee, Craig R., Mias Pretorius, Robert N. Schuck, et al.. (2010). Genetic Variation in Soluble Epoxide Hydrolase ( EPHX2 ) Is Associated With Forearm Vasodilator Responses in Humans. Hypertension. 57(1). 116–122. 48 indexed citations
19.
Knechtle, Beat, et al.. (2008). Effects of a Deca Iron Triathlon on Body Composition - A Case Study. International Journal of Sports Medicine. 29(4). 343–351. 30 indexed citations
20.
Müller, Marcus, et al.. (1995). Einflüsse der lumbalen Periduralanästhesie auf den Gewebe-PO2des Dickdarms beim Menschen. AINS - Anästhesiologie · Intensivmedizin · Notfallmedizin · Schmerztherapie. 30(2). 108–110. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Vijay L. Manthati Breakdown of academic impact, for papers by K. Lockhart Jamieson Breakdown of academic impact, for papers by Jeffrey E. Quigley Breakdown of academic impact, for papers by Ketul R. Chaudhary Breakdown of academic impact, for papers by Arzu Ulu Breakdown of academic impact, for papers by Jürgen R. Schaefer Breakdown of academic impact, for papers by Lucy Yang Breakdown of academic impact, for papers by Ahmed M. Darwesh Breakdown of academic impact, for papers by Esther Knoll Breakdown of academic impact, for papers by Anne M. Estes
Rankless by CCL
2026